CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
American Cannabis Company Inc Company Snapshot
American Cannabis Company Inc operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares American Cannabis Company Inc with three other companies in this sector in the United States: Akers Biosciences Incorporation (2015 sales of $2.12 million of which 100% was Diagnostic Screening), Interleukin Genetics, Inc. ($1.44 million ), and Vermillion Inc ($2.18 million of which 100% was Novel Diagnostic Test).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
American Cannabis Company Inc
  Stock Performance Chart for American Cannabis Company Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): .78
(Figures in U.S. Dollars)
1 Week -11.5%   13 Weeks -8.5%  
4 Weeks 16.1%   52 Weeks 571.0%  
 
American Cannabis Company Inc Key Data:
  Ticker: AMMJ Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 2,799,887
(Year Ending Jan 2016).
Employees: 2
  Currency: U.S. Dollars Market Cap: 36,419,087
  Fiscal Yr Ends: December Shares Outstanding: 46,751,074
  Share Type: Common Closely Held Shares: 29,417,777
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.